Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shurat B Gorieva"'
Autor:
Elena V Oshchepkova, Ani A Avalyan, Anatoliy N Rogoza, Shurat B Gorieva, Marina A Saidova, Irina E Chazova
Publikováno v:
Системные гипертензии, Vol 16, Iss 4, Pp 38-44 (2019)
Aim. To study of the role of the effectiveness of blood pressure control according to the daily monitoring of blood pressure in patients with triple negative breast cancer with arterial hypertension at risk of developing cardiotoxicity with anthracyc
Externí odkaz:
https://doaj.org/article/3f92667a0a8945ff975c3e2f421b522c
Autor:
Ekaterina A Zheleznova, Juliya V Zhernakova, Olga A Pogorelova, Mariia I Tripoten, Nataliia V Blinova, Merab A Shariya, Marina O Azimova, Shurat B Gorieva, Andrei V Maslov, Tatiana V Balakhonova, Irina E Chazova
Publikováno v:
Системные гипертензии, Vol 16, Iss 4, Pp 80-86 (2019)
Aim. To evaluate the common carotid artery (CCA) intima-media complex thickness (IMT) and the presence of atherosclerotic plaques (ASP) in young people with abdominal obesity who don’t have metabolic syndrome and those who have it, as well as a lin
Externí odkaz:
https://doaj.org/article/b893a52878b441d9abee99bbae3966ee
Autor:
Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galyavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publikováno v:
Системные гипертензии, Vol 18, Iss 1, Pp 50-62 (2021)
Aim. To assess the efficacy and safety of Vamloset (amlodipine/valsartan 5/80, 5/160, 10/160 mg) and Co-Vamloset (amlodipine/valsartan/hydrochlorothiazide 10/160/12.5, 10/160/25 mg) in achieving the target levels of blood pressure (BP) in patients wi
Externí odkaz:
https://doaj.org/article/60c64f07123347219ac33339c22c4a57
Autor:
Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publikováno v:
Системные гипертензии, Vol 17, Iss 3, Pp 59-70 (2020)
Aim.Assessment of Vamloset and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-a,
Externí odkaz:
https://doaj.org/article/749491d786994f6493162a7284467d61
Autor:
I E Chazova, Mikhail V. Arkhipov, Olga D. Ostroumova, A N Rogoza, Tatiana R. Kameneva, Tamila Martynyuk, L. A. Khaisheva, Shurat B. Gorieva, Yury I. Grinshtein, O. V. Rodnenkov, Oxana Rotar, A. S. Galyavich
Publikováno v:
Системные гипертензии, Vol 18, Iss 1, Pp 50-62 (2021)
Aim. To assess the efficacy and safety of Vamloset (amlodipine/valsartan 5/80, 5/160, 10/160 mg) and Co-Vamloset (amlodipine/valsartan/hydrochlorothiazide 10/160/12.5, 10/160/25 mg) in achieving the target levels of blood pressure (BP) in patients wi
Autor:
A N Rogoza, Oxana Rotar, Tamila Martynyuk, Shurat B. Gorieva, Tatiana R. Kameneva, Yury I. Grinshtein, Albert S. Galiavich, Mikhail V. Arkhipov, Olga D. Ostroumova, O. V. Rodnenkov, I E Chazova, L. A. Khaisheva
Publikováno v:
Системные гипертензии, Vol 17, Iss 3, Pp 59-70 (2020)
Aim. Assessment of Vamloset® and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-
Autor:
Tatiana V Balakhonova, Shurat B Gorieva, Andrei V Maslov, O A Pogorelova, N V Blinova, M. Azimova, Juliya V. Zhernakova, I E Chazova, Mariia I Tripoten, E. Zheleznova, M.A. Shariya
Publikováno v:
Системные гипертензии, Vol 16, Iss 4, Pp 80-86 (2019)
Aim. To evaluate the common carotid artery (CCA) intima-media complex thickness (IMT) and the presence of atherosclerotic plaques (ASP) in young people with abdominal obesity who don’t have metabolic syndrome and those who have it, as well as a lin
Publikováno v:
Cor et Vasa. 59:e450-e453
U pacientů s recidivujici fibrilaci sini představuje uprava srdecni frekvence atraktivni lecebnou strategii; zpravidla je jednodussi než uprava srdecniho rytmu. Po dosaženi optimalni upravy komorove frekvence zůstavaji pacienti s dlouhodobě trv